Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30… EP News Bureau Feb 4, 2021 Biocon Biologics, a subsidiary of Biocon has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand…
Biocon, Mylan win patent litigation for Insulin Glargine device patent in the US EP News Bureau Mar 11, 2020 Brings Biocon closer to commercialising Semglee in the US in 2020 Biocon has won a US court ruling that invalidated a Sanofi…
